公司資料
CytoSorbents 股價、新聞與催化劑
- 股票代碼:
- CTSO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
5.35 USD (+0.56%)
收盤價
最後更新: 2026年10月21日
30.1M USD
市值
股價為何變動
截至 2026年10月21日，CTSO 上漲 0.56%，收於 $5.35。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
CytoSorbents is a medical technology company focused on blood purification and extracorporeal filtration systems. Its business is centered on critical-care and device-based purification rather than biotech development.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, CytoSorbents sits in medical devices and critical-care technology.
商業模式特徵
The company depends on clinical adoption, hospital procurement, and the expansion of its blood-purification platform.
生技產業定位
CytoSorbents is a niche medtech name whose valuation is tied to adoption and clinical utility.
未來催化劑
- CytoSorbents’ catalysts are CytoSorb adoption, international reimbursement, and any update that shows hospital usage is stabilizing. The company needs to keep proving that the therapy can become a recurring part of critical-care workflow.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。